InvestorQ : What is the update of Bharat Biotech on the Phase 3 clinical trials of its Covaxin?
Niti Shenoi made post

What is the update of Bharat Biotech on the Phase 3 clinical trials of its Covaxin?

Answer
image
ishika Banerjee answered.
4 months ago
Follow

Hyderabad based Bharat Biotech has completed the enrolment of a total of 25,800 volunteers for its Phase-3 clinical trial of the COVID-19 Covaxin. It needs to complete its Phase 3 clinical trials quickly to be able to establish the efficacy tests before it can be administered along with Covishield in the Indian context.

Bharat Biotech will be conducting India's largest Phase-3 trials to test the efficacy of Covaxin and establish its ability to restrict the spread of COVID-19 among people. It may be recollected that Bharat Biotech’s Covaxin was also granted emergency use approval or EUA along with Covishield of Astra Zeneca brought to India by Serum Institute.

The Phase 3 clinical trial essentially means that the consent of the recipient of the vaccine will be taken before administering it. Unlike most of the other Phase 3 clinical tests, Bharat Biotech will not be using the Placebo approach but will direct give the vaccine and monitor the results on a set quadrant.

2 Views